Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

BIOMARKER:

EPAS1 overexpression

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

‹

›

EPAS1 overexpression	Glioblastoma	EPAS1 overexpression	Glioblastoma	bevacizumab + erlotinib Resistant: C3 – Early Trials bevacizumab + erlotinib Resistant : C3	bevacizumab + erlotinib Resistant: C3 – Early Trials bevacizumab + erlotinib Resistant : C3
EPAS1 overexpression	Clear Cell Renal Cell Carcinoma	EPAS1 overexpression	Clear Cell Renal Cell Carcinoma	pazopanib Resistant: C3 – Early Trials pazopanib Resistant : C3	pazopanib Resistant: C3 – Early Trials pazopanib Resistant : C3
EPAS1 overexpression	Hepatocellular Cancer	EPAS1 overexpression	Hepatocellular Cancer	sorafenib Resistant: D – Preclinical sorafenib Resistant : D	sorafenib Resistant: D – Preclinical sorafenib Resistant : D